7,000,000 Shares RANGE RESOURCES CORPORATION Common Stock (par value $0.01 per share) UNDERWRITING AGREEMENT
EXHIBIT
1.1
7,000,000 Shares
RANGE RESOURCES CORPORATION
Common Stock (par value $0.01 per share)
April 17, 2007
April 17, 2007
X.X. Xxxxxx Securities Inc.
Credit Suisse Securities (USA) LLC
Credit Suisse Securities (USA) LLC
As Representatives of the
several Underwriters listed
in Schedule 1 hereto
several Underwriters listed
in Schedule 1 hereto
c/o X.X. Xxxxxx Securities Inc.
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
000 Xxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Credit Suisse Securities (USA) LLC
Eleven Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Eleven Xxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Dear Sirs and Madames:
Range Resources Corporation, a Delaware corporation (the “Company”), proposes to issue and
sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are
acting as representatives (the “Representatives”) an aggregate of 7,000,000 shares of its Common
Stock, par value $0.01 per share (the “Underwritten Shares”) and, for the sole purpose of covering
over-allotments in connection with the sale of the Underwritten Shares, up to an additional
1,050,000 shares of its Common Stock (the “Option Shares”). The Underwritten Shares and the Option
Shares are hereinafter referred to as the “Shares.” The shares of common stock, par value $0.01
per share, of the Company to be outstanding after giving effect to the sales contemplated hereby
are hereinafter referred to as the “Common Stock.”
The Company hereby confirms its agreement with the several Underwriters concerning the
purchase and sale of the Shares, as follows:
1. Registration Statement. The Company has prepared and filed with the Securities and
Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended, and the rules
and regulations of the Commission thereunder (collectively, the “Securities Act”), an automatic
shelf registration statement on Form S-3 (File No. 333-135193), including a prospectus, relating to
the Securities. Such registration statement, as amended on the date hereof, including the
information, if any, deemed pursuant to Rule 430A, 430B or 430C under the Securities Act to be part
of the registration statement at the time of its effectiveness (“Rule 430 Information”), is
referred to herein as the
“Registration Statement”; and as used herein, the term “Preliminary
Prospectus” means the base prospectus included in such registration statement (and any
amendments thereto), the prospectus supplement filed with the Commission pursuant to Rule 424(b)(5)
under the Securities Act on April 17, 2007, and the prospectus included in the Registration
Statement at the time of its effectiveness that omits Rule 430 Information, and the term
“Prospectus” means the prospectus in the form first used (or made available upon request of
purchasers pursuant to Rule 173 under the Securities Act) in connection with confirmation of sales
of the Securities. If the Company has filed an abbreviated registration statement pursuant to Rule
462(b) under the Securities Act (the “Rule 462 Registration Statement”), then any reference herein
to the term “Registration Statement” shall be deemed to include such Rule 462 Registration
Statement. Any reference in this Agreement to the Registration Statement, any Preliminary
Prospectus or the Prospectus shall be deemed to refer to and include the documents incorporated by
reference therein pursuant to Item 12 of Form S-3 under the Securities Act, as of the effective
date of the Registration Statement or the date of such Preliminary Prospectus or the Prospectus, as
the case may be and any reference to “amend”, “amendment” or “supplement” with respect to the
Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to refer to
and include any documents filed after such date under the Securities Exchange Act of 1934, as
amended, and the rules and regulations of the Commission thereunder (collectively, the “Exchange
Act”) that are deemed to be incorporated by reference therein. Capitalized terms used but not
defined herein shall have the meanings given to such terms in the Registration Statement and the
Prospectus.
At or prior to the time when sales of the Securities were first made (the “Time of Sale”), the
Company had prepared the following information (collectively the “Time of Sale Information”): a
Preliminary Prospectus dated April 16, 2007, and each “free-writing prospectus” (as defined
pursuant to Rule 405 under the Securities Act) listed on Annex C hereto.
2. Purchase of the Shares by the Underwriters. (a) The Company agrees to issue and sell the
Underwritten Shares to the several Underwriters as provided in this Agreement, and each
Underwriter, on the basis of the representations, warranties and agreements set forth herein and
subject to the conditions set forth herein, agrees, severally and not jointly, to purchase from the
Company the respective number of Shares set forth opposite such Underwriter’s name in Schedule 1
hereto at a price per share of $34.8288 (the “Purchase Price”).
In addition, subject to the conditions set forth in this Section 2, the Company agrees to
issue and sell the Option Shares to the several Underwriters as provided in this Agreement, and the
Underwriters, on the basis of the representations, warranties and agreements set forth herein and
subject to the
3
conditions set forth herein, shall have the option to purchase, severally and not
jointly, from the Company the Option Shares at the Purchase Price.
If any Option Shares are to be purchased, the number of Option Shares to be purchased by each
Underwriter shall be the number of Option Shares which bears the same ratio to the aggregate number
of Option Shares being purchased as the number of Underwritten Shares set forth opposite the name
of such Underwriter in Schedule 1 hereto bears to the aggregate number of Underwritten Shares being
purchased from the Company by the several Underwriters, subject, however, to such adjustments to
eliminate any fractional Shares as the Representatives in their sole discretion shall make.
The Underwriters may exercise the option to purchase the Option Shares at any time in whole,
or from time to time in part, on or before the thirtieth day following the date of this Agreement,
by written notice from the Representatives to the Company. Such notice shall set forth the
aggregate number of Option Shares as to which the option is being exercised and the date and time
when the Option Shares are to be delivered and paid for which may be the same date and time as the
Closing Date (as hereinafter defined) but shall not be earlier than the Closing Date nor later than
the tenth full business day after the date of such notice. Any such notice shall be given at least
two business days prior to the date and time of delivery specified therein.
(b) The Company understands that the Underwriters intend to make a public offering of the
Shares as soon after the effectiveness of this Agreement as in the judgment of the Representatives
is advisable, and initially to offer the Shares on the terms set forth in the Prospectus. The
Company acknowledges and agrees that the Underwriters may offer and sell Shares to or through any
affiliate of an Underwriter and that any such affiliate may offer and sell Shares purchased by it
to or through any Underwriter.
(c) Payment for the Underwritten Shares shall be made by wire transfer in immediately
available funds to the account specified by the Company to the Representatives in the case of the
Underwritten Shares on April 23, 2007, or at such other time or place on the same or such other
date, not later than the fifth business day thereafter, as the Representatives and the Company may
agree upon in writing. In the case of the Option Shares, payment shall be made consistent with the
terms set forth above on the date and at the time and place specified by the Representatives in the
written notice of the Underwriters’ election to purchase such Option Shares. The time and date of
such payment for the Underwritten Shares is referred to herein as the “Closing Date” and the time
and date for such payment for the Option Shares, if other than the Closing Date, are herein
referred to as the “Additional Closing Date”.
4
Payment for the Underwritten Shares to be purchased on the Closing Date or the Additional
Closing Date, as the case may be, shall be made against delivery through the Depository Trust
Company to the Representatives for the respective accounts of the several Underwriters of the
Shares to be purchased on such date.
(d) The Company acknowledges and agrees that the Underwriters are acting solely in the
capacity of an arm’s length contractual counterparty to the Company with respect to the offering of
Securities contemplated hereby (including in connection with determining the terms of the offering)
and not as a financial advisor or a fiduciary to, or an agent of, the Company or any other person.
Additionally, neither the Representatives nor any other Underwriter is advising the Company or any
other person as to any legal, tax, investment, accounting or regulatory matters in any
jurisdiction. The Company shall consult with its own advisors concerning such matters and shall be
responsible for making its own independent investigation and appraisal of the transactions
contemplated hereby, and the Underwriters shall have no responsibility or liability to the Company
with respect thereto. Any review by the Underwriters of the Company, the transactions contemplated
hereby or other matters relating to such transactions will be performed solely for the benefit of
the Underwriters and shall not be on behalf of the Company.
3. Representations and Warranties of the Company. The Company represents and warrants to and
agrees with each Underwriter that:
(a) Preliminary Prospectus. No order preventing or suspending the use of any
Preliminary Prospectus has been issued by the Commission, and each Preliminary
Prospectus, at the time of filing thereof, complied in all material respects with the
Securities Act and did not contain any untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not
misleading; provided that the Company makes no representation and warranty with respect
to any statements or omissions made in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by such Underwriter
through the Representatives expressly for use in any Preliminary Prospectus.
(b) Time of Sale Information. The Time of Sale Information, at the Time of Sale did
not, and at the Closing Date will not, contain any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they were made, not misleading; provided that the
Company makes no representation and warranty with respect to any statements or omissions
made in reliance upon and in conformity
5
with information relating to any Underwriter
furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in such Time of Sale Information. No statement of material fact
included in the Prospectus has been omitted from the Time of Sale Information and no
statement of material fact included in the Time of Sale Information that is required to
be included in the Prospectus has been omitted therefrom.
(c) Issuer Free Writing Prospectus. Other than the Preliminary Prospectus and the
Prospectus, the Company (including its agents and representatives, other than the
Underwriters) has not made, used, prepared, authorized, approved or referred to and will
not prepare, make, use, authorize, approve or refer to any “written communication” (as
defined in Rule 405 under the Securities Act) that constitutes an offer to sell or
solicitation of an offer to buy the Securities (each such communication by the Company or
such agents and representatives (other than a communication referred to in clause (i)
below) an “Issuer Free Writing Prospectus”) other than (i) any document not constituting
a prospectus pursuant to Section 2(a)(10)(a) of the Securities Act or Rule 134 under the
Securities Act or (ii) the documents listed on Annex C hereto and other written
communications approved in writing in advance by the Representatives. Each such Issuer
Free Writing Prospectus complied in all material respects with the Securities Act, has
been filed in accordance with the Securities Act (to the extent required thereby) and,
when taken together with the Preliminary Prospectus accompanying, or delivered prior to
delivery of, such Issuer Free Writing Prospectus, did not, and at the Closing Date will
not, contain any untrue statement of a material fact or omit to state a material fact
necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided that the Company makes no
representation and warranty with respect to any statements or omissions made in each such
Issuer Free Writing Prospectus in reliance upon and in conformity with information
relating to any Underwriter furnished to the Company in writing by such Underwriter
through the Representatives expressly for use in any Issuer Free Writing Prospectus.
(d) Registration Statement and Prospectus. The Registration Statement is an
“automatic shelf registration statement” as defined under Rule 405 of the Securities Act
that has been filed with the Commission not earlier than three years prior to the date
hereof; and no notice of objection of the Commission to the use of such registration
statement or any post-effective amendment thereto pursuant to Rule 401(g)(2) under the
Securities Act has been received by the Company. No order suspending the effectiveness
of the Registration Statement has been issued by the Commission and no proceeding for
that purpose or
6
pursuant to Section 8A of the Securities Act against the Company or
related to the offering has been initiated or threatened by the Commission; as of the
applicable effective date of the Registration Statement and any amendment thereto, the
Registration Statement complied and will comply in all material respects with the
Securities Act, and did not and will not contain any untrue statement of a material fact
or omit to state a material fact required to be stated therein or necessary in order to
make the statements therein not misleading; and as of the date of the Prospectus and any
amendment or supplement thereto and as of the
Closing Date, the Prospectus will not contain any untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were
made, not misleading; provided that the Company makes no representation and warranty
with respect to any statements or omissions made in reliance upon and in conformity with
information relating to any Underwriter furnished to the Company in writing by such
Underwriter through the Representatives expressly for use in the Registration Statement
and the Prospectus and any amendment or supplement thereto.
(e) Incorporated Documents. The documents incorporated by reference in the
Registration Statement, the Prospectus or the Time of Sale Information, when they were
filed with the Commission, conformed in all material respects to the requirements of the
Securities Act or the Exchange Act, as applicable, and none of such documents contained
any untrue statement of a material fact or omitted to state a material fact required to
be stated therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; and any further documents so
filed and incorporated by reference in the Registration Statement, the Prospectus or the
Time of Sale Information, when such documents become effective or are filed with the
Commission, as the case may be, will conform in all material respects to the requirements
of the Act or the Exchange Act, as applicable, and will not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances under which
they were made, not misleading.
(f) Financial Statements. The audited financial statements of the Company included
or incorporated by reference in the Registration Statement, the Time of Sale Information
and the Prospectus, together with the related notes and schedules, comply in all material
respects with the applicable requirements of the Securities Act and the Exchange Act, as
applicable, and present fairly in all material respects the consolidated financial
position of the Company and its Subsidiaries (as hereinafter
7
defined) as of the dates
indicated and the consolidated results of operations and cash flows of the Company and
its Subsidiaries for the periods specified and have been prepared in compliance in all
material respects with the requirements of the Exchange Act and in conformity with
generally accepted accounting principles (“GAAP”) applied on a consistent basis during
the periods involved and the supporting schedules included or incorporated by reference
in the Registration Statement present fairly the information required to be stated
therein. The other financial and accounting data, including the unaudited financial
statements, included or incorporated by reference in the Registration
Statement, the Time of Sale Information and the Prospectus, have been derived from
the accounting records of the Company and its subsidiaries and present fairly the
information shown therein, in all material respects.
(g) No Material Adverse Change. Subsequent to the respective dates as of which
information is given in the Prospectus, and except as may be otherwise stated or
incorporated by reference in the Prospectus, there has not been (i) any material and
unfavorable change, financial or otherwise, in the business, properties, prospects,
regulatory environment, results of operations or condition (financial or otherwise) of
the Company and its Subsidiaries, taken as a whole, (ii) any transaction entered into by
the Company or any of its Subsidiaries, which is material to the Company and its
Subsidiaries, taken as a whole, or (iii) any obligation, contingent or otherwise,
directly or indirectly, incurred by the Company or any of its Subsidiaries which is
material to the Company and its Subsidiaries, taken as a whole.
(h) Organization and Good Standing of the Company. The Company has been duly
incorporated and is validly existing as a corporation in good standing under the laws of
the State of Delaware, with full corporate power and authority to own, lease and operate
its properties and conduct its business in all material respects as described in the
Registration Statement, the Time of Sale Information and the Prospectus. The Company is
duly qualified to do business as a foreign corporation and is in good standing in each
jurisdiction where the ownership or leasing of its properties or the conduct of its
business requires such qualification, except where the failure to be so qualified and in
good standing would not, individually or in the aggregate, have a material adverse effect
on the operations, business, prospects, properties, financial condition or results of
operation of the Company and its Subsidiaries taken as a whole (a “Material Adverse
Effect”).
(i) Organization and Good Standing of Significant Subsidiaries. Range Energy I,
Inc., Range HoldCo, Inc., Range Production Company, Range Production I, L.P., PMOG
Holdings, Inc.,
8
Range Operating New Mexico, Inc., Great Lakes Energy Partners, L.L.C.,
Range Operating Texas, LLC, Pine Mountain Oil & Gas Inc., Pine Mountain Acquisition,
Inc., Xxxxxx Energy GP, LLC, Xxxxxx Energy LP, LLC, Xxxxxx Oil Properties, LP, Xxxxxx
Energy Management GP, LLC and Xxxxxx Energy, Ltd. (the “Subsidiaries”), include each
subsidiary of the Company that constitutes a “significant subsidiary” of the Company as
defined by Rule 1-02 of Regulation S-X; no other subsidiaries of the Company would,
individually or in the aggregate, constitute such a significant subsidiary; each
Subsidiary has been duly organized and is validly existing as a corporation, limited
liability company or limited partnership and (in those jurisdictions in which good
standing is a relevant concept for such type of entity) is in good standing
under the laws of the jurisdiction of its organization, with full corporate, limited
liability company or partnership power and authority to own, lease and operate its
properties and to conduct its business in all material respects as described in the
Registration Statement, the Time of Sale Information and the Prospectus; each Subsidiary
is duly qualified to do business as a foreign corporation, limited liability company or
limited partnership and (in those jurisdictions in which good standing is a relevant
concept for such type of entity) is in good standing in each jurisdiction where the
ownership or leasing of its properties or the conduct of its business requires such
qualification, except where the failure to be so qualified and in good standing would
not, individually or in the aggregate, have a Material Adverse Effect; all of the
outstanding shares of capital stock of each of the Subsidiaries that is a corporation
have been duly and validly authorized and issued, are fully paid and non-assessable, the
outstanding membership interest of Great Lakes Energy Partners, L.L.C., has been issued
in accordance with the organizational documents of Great Lakes Energy Partners, L.L.C.,
the outstanding partnership interest of Range Production I, L.P., has been issued in
accordance with the terms of the limited partnership agreement of Range Production I,
L.P., the outstanding membership interest of Range Operating Texas, LLC, has been issued
in accordance with the organizational documents of Range Operating Texas, LLC, the
outstanding membership interest of Xxxxxx Energy GP, LLC, has been issued in accordance
with the organizational documents of Xxxxxx Energy GP, LLC, the outstanding membership
interest of Xxxxxx Energy LP, LLC, has been issued in accordance with the organizational
documents of Xxxxxx Energy LP, LLC, the outstanding partnership interest of Xxxxxx Oil
Properties, LP, has been issued in accordance with the terms of the limited partnership
agreement of Xxxxxx Oil Properties, LP, the outstanding membership interest of Xxxxxx
Energy Management GP, LLC, has been issued in accordance with the organizational
documents of Xxxxxx Energy Management GP, LLC, the outstanding partnership
9
interest of
Xxxxxx Energy, Ltd., has been issued in accordance with the terms of the limited
partnership agreement of Xxxxxx Energy, Ltd. and, except as described in the Registration
Statement, the Time of Sale Information and the Prospectus, are owned, directly or
indirectly, by the Company, subject to no security interest, other encumbrance or adverse
claims.
(j) Capitalization. The Company had an authorized and outstanding capitalization as
set forth under the column heading entitled “Actual” in the section of the Registration
Statement, the Time of Sale Information and the Prospectus entitled “Capitalization” and,
as adjusted to give effect to the offering of the Securities and the application of the
net proceeds therefrom as described in the “Use of Proceeds” section of the Registration
Statement, the Time of Sale Information and the
Prospectus; assuming the accuracy of the transaction expenses and the pricing terms
for the offering of the Securities used in the section of the Registration Statement, the
Time of Sale Information and the Prospectus entitled “Capitalization,” the Company would,
as of December 31, 2006, have had an authorized and outstanding capitalization as set
forth under the column heading entitled “As Adjusted” in the section of the Registration
Statement, the Time of Sale Information and the Prospectus entitled “Capitalization”; all
of the issued and outstanding shares of capital stock of the Company have been duly
authorized and validly issued and are fully paid and non-assessable.
(k) Due Authorization. The Company has full right, power and authority to execute
and deliver this Agreement and to perform its obligations hereunder; and all action
required to be taken for the due and proper authorization, execution and delivery of this
Agreement and the consummation of the transactions contemplated thereby has been duly and
validly taken.
(l) Underwriting Agreement. This Agreement has been duly authorized, executed and
delivered by the Company and when duly executed and delivered by the other parties
thereto will be a legal, valid and binding agreement of the Company.
(m) The Shares. The Shares have been duly authorized by the Company and, when
issued and delivered in accordance with the terms of this Agreement and paid for by the
Underwriters, will be validly issued, fully paid and non assessable, and the issuance of
such Shares will not be subject to any preemptive or similar rights.
(n) No Violation, Default or Conflicts. Neither the Company nor any of its
Subsidiaries is in breach or violation of, or in default under
10
(nor has any event
occurred which with notice, lapse of time or both would result in any breach or violation
of, or constitute a default), (i) its respective charter, bylaws or other applicable
formation document or (ii) any indenture, mortgage, deed of trust, bank loan or credit
agreement or other evidence of indebtedness, or any license, lease, material contract or
other material agreement or material instrument to which the Company or any of its
Subsidiaries is a party or by which any of them or any of their properties may be bound
or affected, or under any federal, state, local or foreign law, regulation or rule or any
decree, judgment or order applicable to the Company or any of its Subsidiaries; and the
execution, delivery and performance of this Agreement and the issuance and sale of the
Shares will not conflict with, result in any breach or violation of or constitute a
default under (nor constitute any event which with notice, lapse of time or both would
result in any breach or violation of or constitute a default under), (x) the charter,
bylaws or other applicable formation document of the Company or any of the Subsidiaries
or (y)
under any indenture, mortgage, deed of trust, bank loan or credit agreement or other
evidence of indebtedness, or any license, lease, material contract or other material
agreement or material instrument to which the Company or any of the Subsidiaries is a
party or by which any of them or any of their properties may be bound or affected, or
under any federal, state, local or foreign law, regulation or rule or any decree,
judgment or order applicable to the Company or any of the Subsidiaries, which conflicts,
breaches, violations or defaults listed in clause (y) of this subparagraph (n) would,
individually or in the aggregate, have a Material Adverse Effect.
(o) No Consents Required. No approval, authorization, consent or order of or filing
with any federal, state, local or foreign governmental or regulatory commission, board,
body, authority or agency, or of or with the rules of the New York Stock Exchange, or
approval of the stockholders of the Company, is required in connection with the issuance
and sale by the Company of the Shares or the consummation of the transactions as
contemplated hereby other than (i) as may be required under the securities or blue sky
laws of the various jurisdictions in which the Shares are being sold by the Underwriters;
and (ii) a supplemental listing application for the Shares to be filed with the New York
Stock Exchange.
(p) Legal Proceedings. Except as described in the Registration Statement, the Time
of Sale Information and the Prospectus, (i) there are no actions, suits, claims,
investigations or proceedings pending or threatened or, to the knowledge of the Company
or any of its Subsidiaries after due inquiry, contemplated to which the Company or any of
its Subsidiaries or any of their respective directors or officers is or
11
would be a party
or of which any of their respective properties is or would be subject, at law or in
equity, or before or by any federal, state, local or foreign governmental or regulatory
commission, board, body, authority or agency, which would result in a judgment, decree or
order either (1) having a Material Adverse Effect or (2) preventing the consummation of
the transactions contemplated hereby, (ii) there are no current or pending legal,
governmental or regulatory actions, suits or proceedings that are required under the
Securities Act to be described in the Registration Statement that are not so described in
the Registration Statement, the Time of Sale Information and the Prospectus and (iii)
there are no statutes, regulations or contracts or other documents that are required
under the Securities Act to be filed as exhibits to the Registration Statement or
described in the Registration Statement or the Prospectus that are not so filed as
exhibits to the Registration Statement or described in the Registration Statement, the
Time of Sale Information or the Prospectus.
(q) Independent Accountants. Ernst & Young LLP, whose report on the consolidated
financial statements of the Company, is included or incorporated by reference in the
Registration Statement, the Time of Sale Information and the Prospectus, were at the time
of such report independent public accountants as required by the Securities Act and the
Exchange Act, and the applicable published rules and regulations thereunder.
(r) Title to Real and Personal Property. The Company and each of the Subsidiaries
has good and marketable title to all property (real and personal) described or
incorporated by reference in the Registration Statement, the Time of Sale Information and
the Prospectus as being owned by each of them, free and clear of all liens, claims,
security interests or other encumbrances, except as such do not materially interfere with
the use of such property taken as a whole as described in the Registration Statement, the
Time of Sale Information and the Prospectus; all the real property described in the
Registration Statement, the Time of Sale Information and the Prospectus as being held
under lease by the Company or a Subsidiary is held thereby under valid, subsisting and
enforceable leases with such exceptions as do not materially interfere with the use of
such property taken as a whole as described in the Registration Statement, the Time of
Sale Information and the Prospectus.
(s) Title to Intellectual Property. Each of the Company and its Subsidiaries own,
or have obtained valid and enforceable licenses for, or other adequate rights to use, all
material inventions, patent applications, patents, trademarks (both registered and
unregistered),
12
tradenames, copyrights, trade secrets and other proprietary information
described or incorporated by reference in the Registration Statement, the Time of Sale
Information and the Prospectus as being owned or licensed by them or which are necessary
for the conduct of their respective businesses, except where the failure to own, license
or have such rights would not, individually or in the aggregate, have a Material Adverse
Effect (collectively, “Intellectual Property”); and the conduct of their respective
businesses will not conflict in any material respect with, and neither of the Company nor
any of its Subsidiaries has received notice of any claim or conflict with, any rights of
others.
(t) Investment Company Act. Neither the Company nor any of the Subsidiaries is, nor
after giving effect to the offering and sale of the Shares and the application of the
proceeds thereof as described in the Registration Statement, the Time of Sale Information
and the Prospectus will any of them be, required to register as an “investment company”
under the Investment Company Act of 1940, as amended.
(u) Licenses and Permits. Each of the Company and its Subsidiaries has all
necessary licenses, authorizations, consents and approvals (collectively, “Consents”) and
has made all necessary filings required under any federal, state, local or foreign law,
regulation or rule (“Filings”) and has obtained all necessary Consents from other
persons, in order to conduct their respective businesses, except where the failure to
have any such Consent or to have made any such Filing would not have a Material Adverse
Effect; neither the Company nor any of its Subsidiaries is in violation of, or in default
under, any such Consent which violation or default would have a Material Adverse Effect.
(v) No Labor Disputes. Neither the Company nor its Subsidiaries are involved in any
labor dispute with their respective employees nor, to the knowledge of the Company, is
any such dispute threatened except, in each case, for disputes which would not reasonably
be expected, individually or in the aggregate, to have a Material Adverse Effect.
(w) Compliance With Environmental Laws. The Company and its Subsidiaries and their
properties, assets and operations are in material compliance with, and hold all material
permits, authorizations and approvals required under, Environmental Laws (as defined
below), except to the extent that failure to so comply or to hold such permits,
authorizations or approvals would not, individually or in the aggregate, have a Material
Adverse Effect; there are no past or present events, conditions, circumstances,
activities, practices, actions, omissions or plans that could reasonably be expected to
give rise to any material costs
13
or liabilities to the Company or its Subsidiaries under
Environmental Laws except as would not, individually or in the aggregate, have a Material
Adverse Effect; except as would not, individually or in the aggregate, have a Material
Adverse Effect, the Company and each of the Subsidiaries (i) is not the subject of any
investigation, (ii) has not received any notice or claim, (iii) is not a party to or
affected by any pending or threatened action, suit or proceeding, (iv) is not bound by
any judgment, decree or order or (v) has not entered into any agreement, in each case
relating to any alleged violation of any Environmental Law or any actual or alleged
release or threatened release or cleanup at any location of any Hazardous Materials (as
defined below) (as used herein, “Environmental Law” means any federal, state, local or
foreign law, statute, ordinance, rule, regulation, order, decree, judgment, injunction,
permit, license, authorization or other binding requirement, or common law, relating to
health, safety or the protection, cleanup or restoration of the environment or natural
resources, including those relating to the distribution, processing, generation,
treatment, storage, disposal, transportation, other handling or release or threatened
release of Hazardous Materials, and “Hazardous Materials” means any material
(including, without limitation, pollutants, contaminants, hazardous or toxic
substances or wastes) that is regulated by or may give rise to liability under any
Environmental Law.
(x) Disclosure Controls. The Company has established and maintains disclosure
controls and procedures (as such term is defined in Rule 13a-15 and 15d-15 under the
Exchange Act); such disclosure controls and procedures are designed to ensure that
material information relating to the Company, including its consolidated subsidiaries, is
made known to the Company’s Chief Executive Officer and its Chief Financial Officer by
others within those entities, and such disclosure controls and procedures are effective
to perform the functions for which they were established; the Company’s auditors and the
Audit Committee of the Board of Directors have been advised of: (i) any significant
deficiencies in the design or operation of internal controls which could adversely affect
the Company’s ability to record, process, summarize, and report financial data; and (ii)
any fraud, whether or not material, that involves management or other employees who have
a role in the Company’s internal controls; any material weaknesses in internal controls
have been identified for the Company’s auditors; and since the date of the most recent
evaluation of such disclosure controls and procedures, there have been no significant
changes in internal controls or in other factors that could significantly affect internal
controls, including any corrective actions with regard to significant deficiencies and
material weaknesses.
14
(y) Accounting Controls. The Company and each of the Subsidiaries maintains a
system of internal accounting controls sufficient to provide reasonable assurance that
(i) transactions are executed in accordance with management’s general or specific
authorization; (ii) transactions are recorded as necessary to permit preparation of
financial statements in conformity with generally accepted accounting principles and to
maintain accountability for assets; (iii) access to assets is permitted only in
accordance with management’s general or specific authorization; and (iv) the recorded
accountability for assets is compared with existing assets at reasonable intervals and
appropriate action is taken with respect to any differences.
(z) Insurance. The Company and its Subsidiaries maintain insurance of the types and
in the amounts reasonably believed to be adequate for their business and consistent in
all material respects with insurance coverage maintained by similar companies in similar
businesses, all of which insurance is in full force and effect.
(aa) No Registration Rights. Except as described in the Registration Statement, the
Time of Sale Information and the Prospectus, no person has the right to act as an
underwriter or as a financial advisor to the Company in connection with the offer and
sale of the Shares,
whether as a result of the sale of the Shares as contemplated hereby or otherwise.
(bb) No Stabilization. Neither the Company nor any Affiliate has taken, directly or
indirectly, any action designed, or which has constituted or might reasonably be expected
to cause or result in, under the Exchange Act or otherwise, the stabilization or
manipulation of the price of any security of the Company to facilitate the sale of the
Shares.
(cc) Reserves. Other than as disclosed in the Registration Statement, the Time of
Sale Information and the Prospectus, the proved reserves for crude oil and natural gas
for each of the periods presented in the Registration Statement, the Time of Sale
Information and the Prospectus were prepared in accordance with the Statement of
Financial Accounting Standards No. 69 and Rule 4-10 of Regulation S-X.
(dd) Xxxxxxxx-Xxxxx Act. There is and has been no failure on the part of the
Company and its Subsidiaries or any of the officers and directors of the Company or any
of its Subsidiaries, in their capacities as such, to comply in all material respects with
the provisions of the Xxxxxxxx-Xxxxx Act of 2002 and the rules and regulations in
connection therewith, including without limitation Section 402 related to loans and
Sections 302 and 906 related to certifications.
15
(ee) Status under the Securities Act. The Company is not an ineligible issuer and
is a well-known seasoned issuer, in each case as defined under the Securities Act, in
each case at the times specified in the Securities Act in connection with the offering of
the Shares. The Company has paid the registration fee for this offering pursuant to Rule
456(b)(1) under the Securities Act or will pay such fees within the time period required
by such rule (without giving effect to the proviso therein) and in any event prior to the
Closing Date.
4. Further Agreements of the Company. The Company covenants and agrees with each Underwriter
that:
(a) Required Filings. The Company will file the final Prospectus with the
Commission within the time periods specified by Rule 424(b) and Rule 430A, 430B or 430C
under the Securities Act, will file any Issuer Free Writing Prospectus to the extent
required by Rule 433 under the Securities Act; and will file promptly all reports and any
definitive proxy or information statements required to be filed by the Company with the
Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent
to the date of the Prospectus and for so long as the delivery of a prospectus is required
in connection with
the offering or sale of the Shares; and the Company will furnish copies of the
Prospectus and each Issuer Free Writing Prospectus (to the extent not previously
delivered) to the Underwriters in New York City prior to 10:00 A.M., New York City time,
on the business day next succeeding the date of this Agreement in such quantities as the
Representatives may reasonably request. The Company will pay the registration fees for
this offering within the time period required by Rule 456(b)(i) under the Securities Act
prior to the Closing Date.
(b) Delivery of Copies. The Company will (i) make available to each Underwriter
electronically through XXXXX copies of the Registration Statement as originally filed and
each amendment thereto previously filed, in each case including all exhibits and consents
filed therewith and documents incorporated by reference therein; (ii) make available to
each Underwriter electronically through XXXXX a conformed copy of each amendment to the
Registration Statement filed prior to the later of (x) Closing or (y) the expiration of
the Prospectus Delivery Period or otherwise relating to the Shares, in each case
including all exhibits and consents filed therewith and (iii) deliver, without charge,
during the Prospectus Delivery Period (as defined below), as many copies of the
Prospectus (including all amendments and supplements thereto and documents incorporated
by reference therein) and each Issuer Free Writing Prospectus as the Representatives may
reasonably request. As used herein, the term “Prospectus Delivery
16
Period” means such
period of time after the first date of the public offering of the Shares as in the
opinion of counsel for the Underwriters a prospectus relating to the Shares is required
by law to be delivered (or required to be delivered but for Rule 172 under the Securities
Act) in connection with sales of the Shares by any Underwriter or dealer.
(c) Amendments or Supplements; Issuer Free Writing Prospectuses. Prior to the later
of (i) Closing or (ii) the expiration of the Prospectus Delivery Period, before
preparing, using, authorizing, approving, referring to or filing any Issuer Free Writing
Prospectus, and before filing any amendment or supplement to the Registration Statement
or the Prospectus, the Company will furnish to the Representatives and counsel for the
Underwriters a copy of the proposed Issuer Free Writing Prospectus, amendment or
supplement for review and will not prepare, use, authorize, approve, refer to or file any
such Issuer Free Writing Prospectus or file any such proposed amendment or supplement to
which the Representatives reasonably object.
(d) Notice to the Representatives. The Company will advise the Representatives
promptly, and confirm such advice in writing, (i) when any amendment to the Registration
Statement filed prior to the later of (x) Closing or (y) the expiration of the Prospectus
Delivery Period or otherwise relating to the Shares has been filed or becomes effective;
(ii)
when any supplement to the Prospectus or any amendment to the Prospectus or any
Issuer Free Writing Prospectus relating to the Shares has been filed; (iii) of any
request by the Commission for any amendment to the Registration Statement or any
amendment or supplement to the Prospectus or the receipt of any comments from the
Commission relating to the Registration Statement or any other request by the Commission
for any additional information relating to the Registration Statement or any document
incorporated therein as of the later of (x) Closing or (y) the expiration of the
Prospectus Delivery Period; (iv) of the issuance by the Commission of any order
suspending the effectiveness of the Registration Statement or preventing or suspending
the use of any Preliminary Prospectus or the Prospectus or the initiation or threatening
of any proceeding for that purpose or pursuant to Section 8A of the Securities Act; (v)
of the occurrence of any event within the Prospectus Delivery Period as a result of which
the Prospectus, the Time of Sale Information or any Issuer Free Writing Prospectus as
then amended or supplemented would include any untrue statement of a material fact or
omit to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances existing when the Prospectus,
the Time of Sale Information or any such Issuer Free Writing Prospectus is delivered to a
purchaser, not misleading; (vi) of the receipt by the Company of any
17
notice of objection
of the Commission to the use of the Registration Statement or any post-effective
amendment thereto pursuant to Rule 401(g)(2) under the Securities Act; and (vii) of the
receipt by the Company of any notice with respect to any suspension of the qualification
of the Shares for offer and sale in any jurisdiction or the initiation or threatening of
any proceeding for such purpose; and the Company will use its reasonable best efforts to
prevent the issuance of any such order suspending the effectiveness of the Registration
Statement, preventing or suspending the use of any Preliminary Prospectus or the
Prospectus or suspending any such qualification of the Shares and, if any such order is
issued, will use its reasonable best efforts to obtain as soon as possible the withdrawal
thereof.
(e) Ongoing Compliance. (1) If during the Prospectus Delivery Period (i) any event
shall occur or condition shall exist as a result of which the Prospectus as then amended
or supplemented would include any untrue statement of a material fact or omit to state
any material fact required to be stated therein or necessary in order to make the
statements therein, in the light of the circumstances existing when the Prospectus is
delivered to a purchaser, not misleading or (ii) it is necessary to amend or supplement
the Prospectus to comply with law, the Company will promptly notify the Underwriters
thereof and forthwith prepare and, subject to paragraph (c) above, file with the
Commission and furnish to the Underwriters and to such dealers as the
Representatives may designate, such amendments or supplements to the Prospectus as
may be necessary so that the statements in the Prospectus as so amended or supplemented
will not, in the light of the circumstances existing when the Prospectus is delivered to
a purchaser, be misleading or so that the Prospectus will comply with law and (2) if at
any time prior to the Closing Date (i) any event shall occur or condition shall exist as
a result of which the Time of Sale Information as then amended or supplemented would
include any untrue statement of a material fact or omit to state any material fact
necessary in order to make the statements therein, in the light of the circumstances, not
misleading or (ii) it is necessary to amend or supplement the Time of Sale Information to
comply with law, the Company will promptly notify the Underwriters thereof and forthwith
prepare and, subject to paragraph (c) above, file with the Commission (to the extent
required) and furnish to the Underwriters and to such dealers as the Representatives may
designate, such amendments or supplements to the Time of Sale Information as may be
necessary so that the statements in the Time of Sale Information as so amended or
supplemented will not, in the light of the circumstances, be misleading or so that the
Time of Sale Information will comply with law.
18
(f) Blue Sky Compliance. The Company will qualify the Shares for offer and sale
under the securities or Blue Sky laws of such jurisdictions as the Representatives shall
reasonably request and will continue such qualifications in effect so long as required
for distribution of the Shares; provided that the Company shall not be required to (i)
qualify as a foreign corporation or other entity or as a dealer in securities in any such
jurisdiction where it would not otherwise be required to so qualify, (ii) file any
general consent to service of process in any such jurisdiction or (iii) subject itself to
taxation in any such jurisdiction if it is not otherwise so subject.
(g) Earning Statement. The Company will make generally available to its security
holders and the Representatives as soon as practicable an earning statement that
satisfies the provisions of Section 11(a) of the Securities Act and Rule 158 of the
Commission promulgated thereunder covering a period of at least twelve months beginning
with the first fiscal quarter of the Company occurring after the “effective date” (as
defined in Rule 158) of the Registration Statement.
(h) Clear Market. For a period of 90 days after the date hereof, the Company will
not (i) offer, pledge, announce the intention to sell, sell, contract to sell, sell any
option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase or otherwise transfer or dispose of, directly or
indirectly, any shares of Common Stock or any securities convertible into or exercisable
or exchangeable for Common Stock or (ii) enter into any swap or other agreement that
transfers, in whole or in part, any of the economic
consequences of ownership of the Common Stock, whether any such transaction
described in clause (i) or (ii) above is to be settled by delivery of Common Stock or
such other securities, in cash or otherwise, without the prior written consent of the
Representatives, other than (x) the Shares to be sold hereunder and any shares of Common
Stock of the Company issued upon the exercise of options granted under existing employee
or director equity based compensation plans; or (y) options for shares of Common Stock,
restricted shares of Common Stock or stock appreciation rights granted under such plans
or contributed to the Company’s deferred compensation plans. Notwithstanding the
foregoing and Section 6(k), it is understood that the Company may allow certain executive
officers and directors of the Company, at its sole discretion, to sell up to an aggregate
total of 500,000 shares of Common Stock without further written consent from the
Underwriters, and the Underwriters shall cooperate fully and shall take, or cause to be
taken, all reasonable actions to accommodate this provision.
19
(i) Use of Proceeds. The Company will apply the net proceeds from the sale of the
Shares as described in the Registration Statement, the Time of Sale Information and the
Prospectus under the heading “Use of Proceeds”.
(j) No Stabilization. The Company will not take, directly or indirectly, any action
designed to or that could reasonably be expected to cause or result in any stabilization
or manipulation of the price of the Shares.
(k) Record Retention. The Company will, pursuant to reasonable procedures developed
in good faith, retain copies of each Issuer Free Writing Prospectus that is not filed
with the Commission in accordance with Rule 433 under the Securities Act.
5. Certain Agreements of the Underwriters. Each Underwriter hereby represents and agrees that:
(a) It has not and will not use, authorize use of, refer to, or participate in the
planning for use of, any “free writing prospectus”, as defined in Rule 405 under the
Securities Act (which term includes use of any written information furnished to the
Commission by the Company and not incorporated by reference into the Registration
Statement and any press release issued by the Company) other than (i) a free writing
prospectus that contains no “issuer information” (as defined in Rule 433(h)(2) under the
Securities Act) that was not included (including through incorporation by reference) in
the Preliminary Prospectus or a previously filed Issuer Free Writing Prospectus, (ii) any
Issuer Free Writing Prospectus listed on Annex C or prepared pursuant to Section 3(c) or
Section 4(c) above, or (iii) any free writing prospectus prepared by such
underwriter and approved by the Company in advance in writing (each such free writing
prospectus referred to in clauses (i) or (iii), an “Underwriter Free Writing Prospectus”).
(b) It has not and will not distribute any Underwriter Free Writing Prospectus
referred to in clause (a)(i) in a manner reasonably designed to lead to its broad
unrestricted dissemination.
(c) It has not and will not, without the prior written consent of the Company, use
any free writing prospectus that contains the final terms of the Shares unless such terms
have previously been included in a free writing prospectus filed with
the Commission.
20
(d) It will, pursuant to reasonable procedures developed in good faith, retain copies
of each free writing prospectus used or referred to by it, in accordance with Rule 433
under the Securities Act.
(e) It is not subject to any pending proceeding under Section 8A of the Securities
Act with respect to the offering of the Shares (and will promptly notify the Company if
any such proceeding against it is initiated during the Prospectus Delivery Period).
6. Conditions of Underwriters’ Obligations. The obligation of each Underwriter to purchase
the Underwritten Shares on the Closing Date or the Option Shares on the Additional Closing Date, as
the case may be, as provided herein is subject to the performance by the Company of its covenants
and other obligations hereunder and to the following additional conditions:
(a) Registration Compliance; No Stop Order. No order suspending the effectiveness of the
Registration Statement shall be in effect, and no proceeding for such purpose, pursuant to Rule
401(g)(2) or pursuant to Section 8A under the Securities Act shall be pending before or threatened
by the Commission; the Prospectus and each Issuer Free Writing Prospectus shall have been timely
filed with the Commission under the Securities Act (in the case of a Issuer Free Writing
Prospectus, to the extent required by Rule 433 under the Securities Act) and in accordance with
Section 4(a) hereof; and all requests by the Commission for additional information shall have been
complied with to the reasonable satisfaction of the Representatives.
(b) Representations and Warranties. The representations and warranties of the Company
contained herein shall be true and correct on the date
hereof and on and as of the Closing Date or the Additional Closing Date, as the case may be; and
the statements of the Company and its officers made in any certificates delivered pursuant to this
Agreement shall be true and correct on and as of the Closing Date or the Additional Closing Date,
as the case may be.
(c) No Downgrade. Between the time of execution of this Agreement and the Closing Date or the
Additional Closing Date, as the case may be, there shall not have occurred any downgrading, nor
shall any notice have been given of (i) any intended or potential downgrading or (ii) any watch,
review or possible change that does not indicate an affirmation or improvement in the rating
accorded any securities of or guaranteed by the Company or any Subsidiary by any “nationally
recognized statistical rating organization,” as that term is defined in Rule 436(g)(2) under the
Securities Act.
21
(d) No Material Adverse Change. Between the time of execution of this Agreement and the
Closing Date or the Additional Closing Date, as the case may be, (i) no material adverse change or
development involving a prospective material adverse change in the business, properties,
management, financial condition or results of operations of the Company and the Subsidiaries taken
as a whole shall occur or become known and (ii) no transaction which is material and unfavorable to
the Company (other than as disclosed in the Registration Statement, the Time of Sale Information
and the Prospectus) shall have been entered into by the Company or any of its Subsidiaries, the
effect of which, in any case under this Section 6(d), is so material and adverse as to make it
impracticable to proceed with the offering, sale or delivery of the Shares being delivered at the
time of purchase on the terms and in the manner contemplated in the Registration Statement, the
Time of Sale Information and the Prospectus.
(e) Officer’s Certificate. The Representatives shall have received on and as of the Closing
Date or the Additional Closing Date, as the case may be, a certificate of its Chief Executive
Officer and its Chief Financial Officer in the form attached as Annex B hereto.
(f) Comfort Letters from Ernst & Young LLP. On the date of this Agreement and on the Closing
Date or the Additional Closing Date, as the case may be, Ernst & Young LLP shall have furnished to
the Representatives, at the request of the Company, letters, dated the respective dates of delivery
thereof and addressed to the Underwriters, in form and substance reasonably satisfactory to the
Representatives, containing statements and information of the type customarily included in
accountants’ “comfort letters” to underwriters with respect to the financial statements and certain
financial information contained or incorporated by reference in the Registration Statement, the
Time of Sale Information and the Prospectus; provided that the letter delivered on the
Closing Date or the Additional Closing Date, as the case may be shall use a “cut-off” date no more
than three business days prior to such Closing Date or such Additional Closing Date, as the case
may be.
(g) Opinion of Counsel for the Company. Xxxxxx & Xxxxxx LLP, counsel for the Company, shall
have furnished to the Representatives, at the request of the Company, their written opinion, dated
the Closing Date or the Additional Closing Date, as the case may be, and addressed to the
Underwriters, in form and substance reasonably satisfactory to the Representatives, to the effect
set forth in Annex A hereto.
(i) Opinion of Counsel for the Underwriters. The Representatives shall have received on and
as of the Closing Date or the Additional Closing Date, as the case may be an opinion of Xxxxx Xxxx
& Xxxxxxxx, counsel for the
22
Underwriters, with respect to such matters as the Representatives may
reasonably request, and such counsel shall have received such documents and information as they may
reasonably request to enable them to pass upon such matters.
(j) Approval for listing. The Shares to be delivered on the Closing Date or Additional
Closing Date, as the case may be, shall have been approved for listing on the New York Stock
Exchange, subject to official notice of issuance.
(k) The
“lock-up” agreements, each substantially in the form of Annex D hereto, between you
and the shareholders, officers and directors of the Company listed in
Annex E hereto relating to
sales and certain other dispositions of shares of Common Stock or certain other securities,
delivered to you on or before the date hereof, shall be full force and effect on the Closing Date
or Additional Closing Date, as the case may be.
(l) Additional Documents. On or prior to the Closing Date or the Additional Closing Date, as
the case may be, the Company shall have furnished to the Representatives such further certificates
and documents as the Representatives may reasonably request.
All opinions, letters, certificates and evidence mentioned above or elsewhere in this
Agreement shall be deemed to be in compliance with the provisions hereof only if they are in form
and substance reasonably satisfactory to counsel for the Underwriters.
7. Indemnity and Contribution.
(a) Indemnification of the Underwriters. The Company agrees to indemnify and hold
harmless each Underwriter, its affiliates, directors and officers and each person, if
any, who controls such Underwriter within the meaning of Section 15 of the Securities Act
or Section 20 of the Exchange Act, from and against any and all losses, claims, damages
and liabilities (including, without limitation, reasonable legal fees and other expenses
incurred in connection with any suit, action or proceeding or any claim asserted, as such
fees and expenses are
incurred), joint or several, that arise out of, or are based upon, (i) any untrue
statement or alleged untrue statement of a material fact contained in the Registration
Statement or caused by any omission or alleged omission to state therein a material fact
required to be stated therein or necessary in order to make the statements therein, not
misleading, (ii) or any untrue statement or alleged untrue statement of a material fact
contained in the Prospectus (or any amendment or supplement thereto), any Issuer Free
Writing Prospectus or any Time of Sale Information, or caused by any omission or alleged
omission to state therein a material
23
fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading, in
each case except insofar as such losses, claims, damages or liabilities arise out of, or
are based upon, any untrue statement or omission or alleged untrue statement or omission
made in reliance upon and in conformity with any information relating to any Underwriter
furnished to the Company in writing by such Underwriter through the Representatives
expressly for use therein.
(b) Indemnification of the Company. Each Underwriter agrees, severally and not
jointly, to indemnify and hold harmless the Company, its directors, its officers who
signed the Registration Statement and each person, if any, who controls the Company
within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act
to the same extent as the indemnity set forth in paragraph (a) above, but only with
respect to any losses, claims, damages or liabilities that arise out of, or are based
upon, any untrue statement or omission or alleged untrue statement or omission made in
reliance upon and in conformity with any information relating to such Underwriter
furnished to the Company in writing by such Underwriter through the Representatives
expressly for use in the Registration Statement, the Prospectus (or any amendment or
supplement thereto), any Issuer Free Writing Prospectus or any Time of Sale Information,
it being understood and agreed that the only such information consists of the following:
the paragraphs 10 and 11 of the section entitled “Underwriting” in the Prospectus
relating to stabilization activities.
(c) Notice and Procedures. If any suit, action, proceeding (including any
governmental or regulatory investigation), claim or demand shall be brought or asserted
against any person in respect of which indemnification may be sought pursuant to either
paragraph (a) or (b) above, such person (the “Indemnified Person”) shall promptly notify
the person against whom such indemnification may be sought (the “Indemnifying Person”) in
writing; provided that the failure to notify the Indemnifying Person shall not relieve it
from any liability that it may have under this Section 7 except to the extent that it has
been materially prejudiced (through the forfeiture of substantive rights or defenses) by
such failure; and provided, further, that the failure to notify the Indemnifying
Person shall not relieve it from any liability that it may have to an Indemnified Person
otherwise than under this Section 7. If any such proceeding shall be brought or asserted
against an Indemnified Person and it shall have notified the Indemnifying Person thereof,
the Indemnifying Person shall retain counsel reasonably satisfactory to the Indemnified
Person (who shall not, without the consent of the Indemnified Person, be counsel to the
Indemnifying Person) to represent
24
the Indemnified Person in such proceeding and shall pay
the fees and expenses of such counsel related to such proceeding, as incurred. In any
such proceeding, any Indemnified Person shall have the right to retain its own counsel,
but the fees and expenses of such counsel shall be at the expense of such Indemnified
Person unless (i) the Indemnifying Person and the Indemnified Person shall have mutually
agreed to the contrary, or (ii) the Indemnifying Person has failed within a reasonable
time to retain counsel reasonably satisfactory to the Indemnified Person. It is
understood and agreed that the Indemnifying Person shall not, in connection with any
proceeding or related proceeding in the same jurisdiction, be liable for the fees and
expenses of more than one separate firm (in addition to any local counsel) for all
Indemnified Persons, and that all such fees and expenses shall be reimbursed as they are
incurred. Any such separate firm for any Underwriter, its affiliates, directors and
officers and any control persons of such Underwriter shall be designated in writing by
X.X. Xxxxxx Securities Inc., Credit Suisse Securities (USA) LLC and any such separate
firm for the Company, its directors, its officers who signed the Registration Statement
and any control persons of the Company shall be designated in writing by the Company.
The Indemnifying Person shall not be liable for any settlement of any proceeding effected
without its written consent, but if settled with such consent or if there be a final
judgment for the plaintiff, the Indemnifying Person agrees to indemnify each Indemnified
Person from and against any loss or liability by reason of such settlement or judgment.
Notwithstanding the foregoing sentence, if at any time an Indemnified Person shall have
requested that an Indemnifying Person reimburse the Indemnified Person for fees and
expenses of counsel as contemplated by this paragraph, the Indemnifying Person shall be
liable for any settlement of any proceeding effected without its written consent if (i)
such settlement is entered into more than 30 days after receipt by the Indemnifying
Person of such request and (ii) the Indemnifying Person shall not have reimbursed the
Indemnified Person in accordance with such request prior to the date of such settlement.
No Indemnifying Person shall, without the written consent of the Indemnified Person,
effect any settlement of any pending or threatened proceeding in respect of which any
Indemnified Person is or could have been a party and indemnification could have been
sought hereunder by such Indemnified Person, unless such settlement (x) includes an
unconditional release of
such Indemnified Person, in form and substance reasonably satisfactory to such
Indemnified Person, from all liability on claims that are the subject matter of such
proceeding and (y) does not include any statement as to or any admission of fault,
culpability or a failure to act by or on behalf of any Indemnified Person.
25
(d) Contribution. If the indemnification provided for in paragraphs (a) and (b)
above is unavailable to an Indemnified Person or insufficient in respect of any losses,
claims, damages or liabilities referred to therein, then each Indemnifying Person under
such paragraph, in lieu of indemnifying such Indemnified Person thereunder, shall
contribute to the amount paid or payable by such Indemnified Person as a result of such
losses, claims, damages or liabilities (i) in such proportion as is appropriate to
reflect the relative benefits received by the Company on the one hand and the
Underwriters on the other from the offering of the Shares or (ii) if the allocation
provided by clause (i) is not permitted by applicable law, in such proportion as is
appropriate to reflect not only the relative benefits referred to in clause (i) but also
the relative fault of the Company on the one hand and the Underwriters on the other in
connection with the statements or omissions that resulted in such losses, claims, damages
or liabilities, as well as any other relevant equitable considerations. The relative
benefits received by the Company on the one hand and the Underwriters on the other shall
be deemed to be in the same respective proportions as the net proceeds (before deducting
expenses) received by the Company from the sale of the Shares and the total underwriting
discounts and commissions received by the Underwriters in connection therewith, in each
case as set forth in the table on the cover of the Prospectus, bear to the aggregate
offering price of the Shares. The relative fault of the Company on the one hand and the
Underwriters on the other shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information supplied by the Company
or by the Underwriters and the parties’ relative intent, knowledge, access to information
and opportunity to correct or prevent such statement or omission.
(e) Limitation on Liability. The Company and the Underwriters agree that it would
not be just and equitable if contribution pursuant to this Section 7 were determined by
pro rata allocation (even if the Underwriters were treated as one entity for such
purpose) or by any other method of allocation that does not take account of the equitable
considerations referred to in paragraph (d) above. The amount paid or payable by an
Indemnified Person as a result of the losses, claims, damages and liabilities referred to
in paragraph (d) above shall be deemed to include, subject to the limitations set forth
above, any legal or other expenses incurred by such Indemnified Person in connection with
any such action or claim. Notwithstanding the provisions of this Section
7, in no event shall an Underwriter be required to contribute any amount in excess
of the amount by which the total underwriting discounts and commissions received by such
Underwriter with respect to the offering of
26
the Shares exceeds the amount of any damages
that such Underwriter has otherwise been required to pay by reason of such untrue or
alleged untrue statement or omission or alleged omission. No person guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be
entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Underwriters’ obligations to contribute pursuant to this Section
7 are several in proportion to their respective purchase obligations hereunder and not
joint.
(f) Non-Exclusive Remedies. The remedies provided for in this Section 7 are not
exclusive and shall not limit any rights or remedies which may otherwise be available to
any Indemnified Person at law or in equity.
8. Effectiveness. This Agreement shall become effective upon the execution and delivery hereof
by the parties hereto.
9. Termination. The obligations of the Underwriters hereunder shall be subject to termination
in the absolute discretion of the Representatives, acting on behalf of the Underwriters, if after
the execution of this Agreement and prior to the completion of the sale of the Shares on the
Closing Date, there shall have occurred: (i) a suspension or material limitation in trading in
securities generally on the New York Stock Exchange, the American Stock Exchange or the NASDAQ;
(ii) a suspension or material limitation in trading in the Company’s securities on the New York
Stock Exchange; (iii) a general moratorium on commercial banking activities declared by either
federal or New York State authorities or a material disruption in commercial banking or securities
settlement or clearance services in the United States; (iv) an outbreak or escalation of
hostilities or acts of terrorism involving the United States or a declaration by the United States
of a national emergency or war; or (v) any other calamity or crisis or any change in financial,
political or economic conditions in the United States or elsewhere, if the effect of any such event
specified in clause (iv) or (v) in the judgment of the Underwriters makes it impracticable or
inadvisable to proceed with the offering, sale or delivery of the Shares on the terms and in the
manner contemplated by this Agreement, the Time of Sale Information and the Prospectus.
If the Underwriters elect to terminate this Agreement as provided in this Section 9, the
Company shall be notified as provided for herein.
If the sale to the Underwriters of the Shares, as contemplated by this Agreement, is not
carried out by the Underwriters for any reason permitted under this Agreement or if such sale is
not carried out because the Company shall be
unable to comply or does not comply with any of the terms of this Agreement, the
27
Company shall
not be under any obligation or liability under this Agreement (except to the extent provided in
Sections 7 and 11 hereof), and the Underwriters shall be under no obligation or liability to the
Company under this Agreement (except to the extent provided in Section 7 hereof).
10. Defaulting Underwriter. (a) If, on the Closing Date or the Additional Closing Date, as
the case may be, any Underwriter defaults on its obligation to purchase the Shares that it has
agreed to purchase hereunder on such date, the non-defaulting Underwriters may in their discretion
arrange for the purchase of such Shares by other persons satisfactory to the Company on the terms
contained in this Agreement. If, within 36 hours after any such default by any Underwriter, the
non-defaulting Underwriters do not arrange for the purchase of such Shares, then the Company shall
be entitled to a further period of 36 hours within which to procure other persons satisfactory to
the non-defaulting Underwriters to purchase such Shares on such terms. If other persons become
obligated or agree to purchase the Shares of a defaulting Underwriter, either the non defaulting
Underwriters or the Company may postpone the Closing Date or the Additional Closing Date, as the
case may be, for up to five full business days in order to effect any changes that in the opinion
of counsel for the Company or counsel for the Underwriters may be necessary in the Registration
Statement and the Prospectus or in any other document or arrangement, and the Company agrees to
promptly prepare any amendment or supplement to the Registration Statement and the Prospectus that
effects any such changes. As used in this Agreement, the term “Underwriter” includes, for all
purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule
1 hereto that, pursuant to this Section 10, purchases Shares that a defaulting Underwriter agreed
but failed to purchase.
(b) If, after giving effect to any arrangements for the purchase of the Shares of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company
as provided in paragraph (a) above, the aggregate number of Shares that remain
unpurchased on the Closing Date or the Additional Closing Date, as the case may be, does
not exceed one-eleventh of the aggregate number of Shares to be purchased on such date,
then the Company shall have the right to require each non-defaulting Underwriter to
purchase the number of Shares that such Underwriter agreed to purchase hereunder on such
date plus such Underwriter’s pro rata share (based on the number of Shares that such
Underwriter agreed to purchase on such date) of the Shares of such defaulting Underwriter
or Underwriters for which such arrangements have not been made.
(c) If, after giving effect to any arrangements for the purchase of the Shares of a
defaulting Underwriter or Underwriters by the non-defaulting Underwriters and the Company
as provided in paragraph (a)
28
above, the aggregate number of Shares that remain
unpurchased on the
Closing Date or the Additional Closing Date, as the case may be, exceeds
one-eleventh of the aggregate amount of Shares to be purchased on such date, or if the
Company shall not exercise the right described in paragraph (b) above, then this
Agreement or, with respect to any Additional Closing Date, the obligation of the
Underwriters to purchase Shares on the Additional Closing Date, as the case may be, shall
terminate without liability on the part of the non-defaulting Underwriters. Any
termination of this Agreement pursuant to this Section 10 shall be without liability on
the part of the Company, except that the Company will continue to be liable for the
payment of expenses as set forth in Section 11 hereof and except that the provisions of
Section 7 hereof shall not terminate and shall remain in effect.
(d) Nothing contained herein shall relieve a defaulting Underwriter of any liability
it may have to the Company or any non-defaulting Underwriter for damages caused by its
default.
11. Payment of Expenses. (a) Whether or not the transactions contemplated in this Agreement
are consummated or this Agreement is terminated, the Company will pay or cause to be paid all
expenses incident to the performance of its obligations under this Agreement, including, without
limitation, (i) the fees, disbursements and expenses of the Company’s counsel and the Company’s
accountants in connection with the issuance and sale of the Shares and all other fees and expenses
in connection with the preparation of the Registration Statement, the Time of Sale Information and
the Prospectus and all amendments and supplements thereto, including all printing costs associated
therewith, and the furnishing of copies thereof to the Underwriters and to dealers (including costs
of mailing and shipment), (ii) the cost of preparing stock certificates; (iii) the costs and
charges of any transfer agent and any registrar; (iv) all expenses and application fees incurred in
connection with any filing with, and clearance of the offering by, the National Association of
Securities Dealers, Inc., (v) the preparation and, as applicable, printing and delivery of this
Agreement, and the furnishing of copies thereof to the Underwriters and to dealers (including costs
of mailing and shipment), and also of any other document related to the issuance, offer, sale and
delivery of the Shares, (vi) all expenses in connection with the qualification of the Shares for
offering and sale under state laws and the cost of printing and furnishing of copies of any blue
sky memorandum to the Underwriters and to dealers (including filing fees and the reasonable fees
and disbursements of counsel for the Underwriters in connection with such qualification and in
connection with such blue sky memorandum), (vii) the costs and expenses of the Company relating to
presentations or meetings undertaken in connection with the marketing of the offering of the Shares
to prospective investors and the Underwriters’ respective sales forces, including, without
limitation, expenses associated with the production of road show slides
and
29
graphics, fees and
expenses of any consultants engaged in connection with the road show presentations, travel, lodging
and other expenses incurred by the
representatives and officers of the Company and any such consultants, (viii) all expenses and
application fees related to the listing of the Shares on the New York Stock Exchange and (ix) all
other costs and expenses incident to the performance of the Company’s obligations hereunder for
which provision is not otherwise made in this Section 11.
(b) If the Shares are not delivered for any reason other than the default by an
Underwriter of its obligations hereunder, the Company will reimburse such Underwriter for
all out-of-pocket expenses (including the reasonable fees and disbursements of its
counsel) reasonably incurred by such Underwriter in connection with this Agreement or the
offering contemplated hereunder.
12. Persons Entitled to Benefit of Agreement. This Agreement shall inure to the benefit of
and be binding upon the parties hereto and their respective successors and the officers and
directors and any controlling persons referred to in Section 7 hereof. Nothing in this Agreement
is intended or shall be construed to give any other person any legal or equitable right, remedy or
claim under or in respect of this Agreement or any provision contained herein. No purchaser of
Shares from any Underwriter shall be deemed to be a successor merely by reason of such purchase.
13. Survival. The respective indemnities, rights of contribution, representations, warranties
and agreements of the Company and the Underwriters contained in this Agreement or made by or on
behalf of the Company or the Underwriters pursuant to this Agreement or any certificate delivered
pursuant hereto shall survive the delivery of and payment for the Shares and shall remain in full
force and effect, regardless of any termination of this Agreement or any investigation made by or
on behalf of the Company or the Underwriters.
14. Miscellaneous. (a) Authority of the Representatives. Any action by the Underwriters
hereunder may be taken by X.X. Xxxxxx Securities Inc. and Credit Suisse Securities (USA) LLC on
behalf of the Underwriters, and any such action taken by X.X. Xxxxxx Securities Inc. and Credit
Suisse Securities (USA) LLC shall be binding upon the Underwriters.
(b) Notices. All notices and other communications hereunder shall be in writing and
shall be deemed to have been duly given if mailed or transmitted and confirmed by any
standard form of telecommunication. Notices to the Underwriters shall be given to the
Representatives c/o X.X. Xxxxxx Securities Inc., 000 Xxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx
00000 (fax: (000) 000-0000); Attention: Equity Syndicate Desk, and Credit Suisse
Securities (USA) LLC, Eleven
00
Xxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000; Attention:
LCD-IBD, and if to the Company, shall be sufficient in all respects if delivered or sent
to the Company at the offices of the Company at 000 Xxxx Xxxxxx,
Xxxx Xxxxx, Xxxxx 00000, Attention: Xxxxxx X. Xxxxxx, facsimile no. (000) 000-0000.
(c) Governing Law. This Agreement shall be governed by and construed in accordance
with the laws of the State of New York.
(d) Counterparts. This Agreement may be signed in counterparts (which may include
counterparts delivered by any standard form of telecommunication), each of which shall be
an original and all of which together shall constitute one and the same instrument.
(e) Amendments or Waivers. No amendment or waiver of any provision of this
Agreement, nor any consent or approval to any departure therefrom, shall in any event be
effective unless the same shall be in writing and signed by the parties hereto.
(f) Headings. The headings herein are included for convenience of reference only
and are not intended to be part of, or to affect the meaning or interpretation of, this
Agreement.
31
If the foregoing is in accordance with your understanding, please indicate your acceptance of
this Agreement by signing in the space provided below.
Very truly yours, | ||||||
RANGE RESOURCES CORPORATION | ||||||
By: | ||||||
Title: |
Accepted as of the date hereof | ||||
X.X. XXXXXX SECURITIES INC. | ||||
CREDIT SUISSE SECURITIES (USA) LLC | ||||
Acting severally on behalf of themselves and the several Underwriters listed in Schedule 1 hereto. | ||||
By: X.X. XXXXXX SECURITIES INC. | ||||
By: |
||||
Title: | ||||
By: CREDIT SUISSE SECURITIES (USA) LLC | ||||
By: |
||||
Title: |
Schedule 1
Underwriter | Number of Shares | |
X.X. Xxxxxx Securities Inc. |
2,135,000 | |
Credit Suisse Securities (USA) LLC |
1,085,000 | |
Deutsche Bank Securities Inc. |
560,000 | |
Friedman, Billings, Xxxxxx & Co., Inc. |
560,000 | |
Xxxxxx Xxxxxxx & Co. Incorporated |
560,000 | |
Xxxxxxx Xxxxx & Associates, Inc. |
350,000 | |
Xxxxxxx Rice & Company L.L.C. |
315,000 | |
KeyBanc Capital Markets Inc. |
315,000 | |
BMO Capital Markets Corp. |
140,000 | |
Calyon Securities (USA) Inc. |
140,000 | |
Fortis Securities LLC |
140,000 | |
Natexis Bleichroeder Inc. |
140,000 | |
Xxxxxxxxx Energy Partners, Inc. |
140,000 | |
RBC Capital Markets Corporation |
140,000 | |
Xxxxxxx & Company International |
140,000 | |
SunTrust Capital Markets, Inc. |
140,000 |
Total | 7,000,000 | |||||
ANNEX A
[Form of Opinion of Counsel for the Company]
(a) The Registration Statement is an “automatic shelf registration statement” as
defined under Rule 405 of the Securities Act that has been filed with the Commission not
earlier than three years prior to the date of the Underwriting Agreement; each of the
Preliminary Prospectus and the Prospectus was filed with the Commission pursuant to the
subparagraph of Rule 424 under the Securities Act specified in such opinion on the date
specified therein; and, to the best knowledge of such counsel, no order suspending the
effectiveness of the Registration Statement has been issued, no notice of objection of
the Commission to the use of such registration statement or any post-effective amendment
thereto pursuant to Rule 401(g)(2) under the Securities Act has been received by the
Company and no proceeding for that purpose or pursuant to Section 8A of the Securities
Act against the Company or in connection with the offering is pending or threatened by
the Commission.
(b) The Registration Statement, the Preliminary Prospectus and the Prospectus (other
than (a) the financial statements and related schedules thereto, including the notes
thereto and the independent registered public accounting firm’s report thereon and (b)
the other financial and statistical data derived therefrom and that is included or
incorporated by reference therein and (c) the oil and gas reserve reports and related
reserve information contained or incorporated by reference therein, as to which such
counsel need express no opinion) appear on their face to be appropriately responsive in
all material respects to the requirements of the Securities Act; and each Issuer Free
Writing Prospectus included in the Time of Sale Information contains the legend required
by Rule 433 of the Securities Act and has been filed with the Commission to the extent,
and within the time period, required pursuant to Rule 433 of the Securities Act.
(c) The Company is validly existing and in good standing as a corporation under the
laws of the State of Delaware with all requisite corporate power and authority to own its
properties and conduct its business in all material respects as described in the
Registration Statement, the Time of Sale Information and the Prospectus.
(d) Each of the Subsidiaries (other than Range Production I, L.P., Pine Mountain Oil
& Gas Inc., Xxxxxx Energy Management GP, LLC and Xxxxxx Energy, Ltd.) is validly existing
and in good standing under the laws of the State of Delaware; each of Range Production I,
A-1
L.P., Xxxxxx Energy Management GP, LLC and Xxxxxx Energy, Ltd. is validly existing under
the laws of the State of Texas and Xxxxxx Energy
Management GP, LLC is in good standing under the laws of the State of Texas; Pine
Mountain Oil & Gas Inc. is validly existing under the laws of the State of Virginia; each
of the Subsidiaries has all requisite corporate, limited liability company or partnership
power and authority to own its respective properties and to conduct its respective
business, in all material respects as described in the Registration Statement, the Time
of Sale Information and the Prospectus.
(e) The Company and each of the Subsidiaries listed on Schedule 1 of such opinion,
other than Xxxxxx Energy, Ltd. and Range Production I, L.P., are (i) duly qualified or
licensed to do business as a foreign corporation, foreign limited partnership or limited
liability company in each jurisdiction listed across from each such entity’s name on
Schedule 1 of such opinion and (ii) in good standing in each jurisdiction listed across
from each such entity’s name on Schedule 1 of such opinion, other than those
jurisdictions in which good standing is not a relevant concept for such entity – such
counsel may separately specify on Schedule 1 which states the opinion in clause (ii)
speaks to and, if verbal or written confirmation of good standing is not available from
New York by closing, may omit New York from such opinion.
(f) The documents incorporated by reference in the Time of Sale Information and the
Prospectus or any further amendment or supplement thereto made by the Company prior to
the Closing Date (except for (a) the financial statements and related schedules thereto,
including the notes thereto and the independent registered public accounting firm’s
report thereon, (b) the other financial and statistical data derived therefrom and that
is included or incorporated by reference therein and (c) the oil and gas reserve reports
and related reserve information contained or incorporated by reference therein, as to
which we express no opinion), when they were filed with the Commission, appear on their
face to be appropriately responsive in all material respects with the requirements of the
Securities Act or the Exchange Act and the rules and regulations of the Commission
thereunder.
(g) The execution, delivery and performance of the Underwriting Agreement by the
Company, the issuance and sale of the Shares being delivered on the Closing Date or the
Additional Closing Date, as the case may be, by the Company and the consummation by the
Company of the transactions contemplated thereby do not conflict with, or result in any
breach of, or constitute a default under (nor constitute any event which with notice,
lapse of time, or both would constitute a breach or default under) (A) any provisions of
the Charter or Bylaws of the
A-2
Company, (B) any Applicable Contract, or (C) assuming
compliance with all applicable state securities laws and assuming the accuracy of the
representations and warranties of the Underwriters contained in the Underwriting
Agreement, any federal or Texas or Delaware state law,
regulation or rule or, to our knowledge and without having investigated governmental
records or court dockets, any decree, judgment or order applicable to the Company or any
of the Subsidiaries, except, in the case of clause (B) and (C), for such conflicts,
breaches or defaults that would not, individually or in the aggregate, result in a
Material Adverse Effect and, in the case of clause (C), such counsel need express no
opinion with respect to the anti fraud provisions of federal securities laws or with
respect to state securities laws or Blue Sky laws.
(h) The Underwriting Agreement has been duly authorized, executed and delivered by
the Company.
(i) The Shares to be issued and sold by the Company hereunder have been duly
authorized, and when delivered to and paid for by the Underwriters in accordance with the
terms of this Agreement, will be validly issued, fully paid and non-assessable and the
issuance of the Shares is not subject to any preemptive or similar rights.
(j) No approval, authorization, consent or order of or filing with any federal,
state, local or foreign governmental or regulatory commission, board, body, authority or
agency, or of or with the rules of the New York Stock Exchange, or approval of the
stockholders of the Company, is required in connection with the issuance and sale by the
Company of the Shares or the consummation of the transactions as contemplated in the
Underwriting Agreement other than (i) as may be required under the securities or blue sky
laws of the various jurisdictions in which the Shares are being sold by the Underwriters;
and (ii) a supplemental listing application for the Shares to be filed with the New York
Stock Exchange
(k) The statements set forth in the Time of Sale Information and the Prospectus
under the caption “Description of Capital Stock”, insofar as they purport to constitute
summaries of matters of law or regulation or legal conclusions, are accurate summaries in
all material respects.
(l) The Company is not, and after giving effect to the offering and sale of the
Shares and the application of the proceeds thereof as described in the Registration
Statement, the Time of Sale Information and the Prospectus will not be, required to
register as an “investment
A-3
company” as defined in the Investment Company Act of 1940, as
amended.
(m) Based upon our participation in conferences with officers and other
representatives of the Company, representatives of the independent public accountants of
the Company and representatives of the Underwriters at which the contents of the
Registration Statement, the
Time of Sale Information and the Prospectus and any amendment and supplement thereto
and related matters were discussed and without any additional inquiry or due diligence
(except as necessary to express the opinions set forth above), although we have not
conducted any independent investigations with regard to the information in the
Registration Statement, the Time of Sale Information and the Prospectus and are not
passing upon and do not assume any responsibility for the accuracy, completeness or
fairness of the statements contained in the Registration Statement, the Time of Sale
Information and the Prospectus (except to the extent stated in paragraph (k) above), no
facts have come to our attention which lead us to believe that the Registration
Statement, at the time of its effective date (including the information, if any, deemed
pursuant to Rule 430A, 430B or 430C to be part of the Registration Statement at the time
of effectiveness), contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary to make the statements therein
not misleading, that the Time of Sale Information, at the Time of Sale (which such
counsel may assume to be the date of the Underwriting Agreement) contained any untrue
statement of a material fact or omitted to state a material fact necessary to make the
statements therein, in the light of the circumstances under which they were made, not
misleading or that the Prospectus or any amendment or supplement thereto as of its date
and the Closing Date contains any untrue statement of a material fact or omits to state a
material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading (except for (a) the financial statements and
related schedules thereto, including the notes thereto, and the independent registered
public accounting firm’s report thereon, (b) the other financial and statistical data
that is included or incorporated by reference therein and (c) the oil and gas reserve
reports and related reserve information contained or incorporated by reference therein,
as to which we express no opinion).
A-4
SCHEDULE 1
• | Range Resources Corporation Texas, Oklahoma | ||
• | Range HoldCo, Inc. New York, Oklahoma, Pennsylvania, Ohio | ||
• | Range Production Company Louisiana, Mississippi, New Mexico, Oklahoma, Texas | ||
• | Great Lakes Energy Partners, L.L.C. – Ohio, Pennsylvania | ||
• | Range Operating New Mexico, Inc. – New Mexico | ||
• | Range Production I, L.P. – Louisiana, Mississippi | ||
• | Range Operating Texas, LLC – Texas | ||
• | Pine Mountain Oil & Gas Inc – West Virginia | ||
• | Xxxxxx Energy GP, LLC – Texas | ||
• | Xxxxxx Energy, Ltd. – Mississippi, Oklahoma |
A-5
ANNEX B
OFFICERS’ CERTIFICATE
1. I have reviewed the Registration Statement, the Time of Sale Information and the
Prospectus.
2. The representations and warranties of the Company as set forth in the Underwriting
Agreement are true and correct as of the time of purchase.
3. The Company has performed all of its obligations under the Underwriting Agreement as are to
be performed at or before the time of purchase.
4. The condition set forth in Section 6(d) (No Material Adverse Change) of the Underwriting
Agreement has been met.
B-1
ANNEX C
There are
no free writing prospectuses included in the Time of Sale Information.
C-1
ANNEX D
LOCK-UP AGREEMENT
April __, 2007
X.X. XXXXXX SECURITIES INC.
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
000 Xxxx Xxxxxx
Xxx Xxxx, XX 00000
Ladies and Gentlemen:
The undersigned understands that X.X. Xxxxxx Securities Inc., as representative of the several
Underwriters (the “Underwriters”) proposes to enter into an Underwriting Agreement (the
“Underwriting Agreement”) with Range Resources Corporation, a Delaware corporation (the “Company”),
providing for the public offering (the “Public Offering”) by the Underwriters of shares (the
“Shares”) of the common stock, par value $0.01 per share, of the Company (the “Common Stock”).
In consideration of the Underwriters’ agreement to purchase and make the Public Offering, and
for other good and valuable consideration receipt of which is hereby acknowledged, subject to any
applicable carve-outs granted in the Underwriting Agreement, the undersigned hereby agrees that,
without the prior written consent of X.X. Xxxxxx Securities Inc., on behalf of the Underwriters,
the undersigned will not, during the period ending 90 days after the date of the prospectus
relating to the Public Offering (the “Prospectus”), (1) offer, pledge, announce the intention to
sell, sell, contract to sell, sell any option or contract to purchase, purchase any option or
contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose
of, directly or indirectly, any shares of Common Stock, or any securities convertible into or
exercisable or exchangeable for Common Stock (including without limitation, Common Stock which may
be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations
of the Securities and Exchange Commission and securities which may be issued upon exercise of a
stock option or warrant) or (2) enter into any swap or other agreement that transfers, in whole or
in part, any of the economic consequences of ownership of the Common Stock, whether any such
transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or
such other securities, in cash or otherwise. In addition, the undersigned agrees that, without the
prior written consent of X.X. Xxxxxx Securities Inc., it will not, during the period ending 90 days
after the date of the Prospectus, make any demand for or exercise any right with respect to, the
D-1
registration of any shares of Common Stock or any security convertible into or exercisable or
exchangeable for Common Stock.
In furtherance of the foregoing, the Company, and any duly appointed transfer agent for the
registration or transfer of the securities described herein, are hereby authorized to decline to
make any transfer of securities if such transfer would constitute a violation or breach of this
Letter Agreement.
The undersigned hereby represents and warrants that the undersigned has full power and
authority to enter into this Letter Agreement. All authority herein conferred or agreed to be
conferred and any obligations of the undersigned shall be binding upon the successors, assigns,
heirs or personal representatives of the undersigned.
The undersigned understands that, if the Underwriting Agreement does not become effective, or
if the Underwriting Agreement (other than the provisions thereof which survive termination) shall
terminate or be terminated prior to payment for and delivery of the Common Stock to be sold
thereunder, the undersigned shall be released form all obligations under this Letter Agreement.
The undersigned understands that the Underwriters are entering into the Underwriting Agreement
and proceeding with the Public Offering in reliance upon this Letter Agreement.
D-2
This lock-up agreement shall be governed by and construed in accordance with the laws of the
State of New York, without regard to the conflict of laws principles thereof.
Very truly yours, |
||||
By: | ||||
Name: | ||||
Title: | ||||
D-3
ANNEX E
Lock-up Agreements
Xxxxxxx X. Xxxxxxxxx
Xxxxxxx X. Dub
V. Xxxxxxx Xxxxx
Xxxxx Xxxxxxxxx
Xxxxxxxx X. Xxxxxx
Xxxxx X. XxXxxxxx
Xxxx X. Xxxxxxxxx
Xxxxxxx X. Xxxxxxx
Xxxxxx X. Xxxxx
Xxxxx X. Xxxxx
Xxxx X. Xxxxxxxx
Xxxxxx X. Xxxxxx
Xxxx X. Xxxxxxx
Xxxxxxx X. Dub
V. Xxxxxxx Xxxxx
Xxxxx Xxxxxxxxx
Xxxxxxxx X. Xxxxxx
Xxxxx X. XxXxxxxx
Xxxx X. Xxxxxxxxx
Xxxxxxx X. Xxxxxxx
Xxxxxx X. Xxxxx
Xxxxx X. Xxxxx
Xxxx X. Xxxxxxxx
Xxxxxx X. Xxxxxx
Xxxx X. Xxxxxxx
E-1